Introduction: When to Seek Diagnostic Testing

Graves’ disease is an autoimmune condition that causes the thyroid gland to produce too much thyroid hormone, a state known as hyperthyroidism, which means the thyroid is overactive. If you experience symptoms such as unexplained weight loss despite eating more, a racing or irregular heartbeat, trembling hands, excessive sweating, heat intolerance, anxiety, nervousness, or unusual fatigue, it’s important to see your doctor as soon as possible.^[1] Women and people over the age of 30 are more likely to develop Graves’ disease, though anyone can be affected at any age.^[2]

Early diagnosis matters because untreated Graves’ disease can lead to serious health problems. When the thyroid is overactive for an extended period, it can cause complications such as heart rhythm problems called atrial fibrillation, which increases the risk of stroke and heart failure.^[3] The condition can also weaken bones, leading to osteoporosis, which makes fractures more likely. In rare cases, a life-threatening condition called thyroid storm can occur when the thyroid suddenly releases a large amount of hormone in a short time.^[8]

You should seek diagnostic testing if you notice changes in your body that suggest your metabolism is speeding up. These changes might include feeling hot all the time, having frequent bowel movements, trouble sleeping, or noticing that your eyes appear larger or bulge outward. Some people also notice swelling at the front of the neck, which is called a goiter and indicates an enlarged thyroid gland.^[1] In older adults, especially those with heart conditions, the symptoms may be less obvious but can include heart-related chest pain or heart failure, making prompt diagnosis even more critical.^[5]

People with a family history of Graves’ disease or other autoimmune conditions are at higher risk and should be particularly alert to symptoms. The condition tends to run in families, and having a close relative with thyroid problems increases your chances of developing the disease.^[3] Other risk factors include smoking, recent pregnancy, high stress levels, and having other autoimmune disorders such as type 1 diabetes, rheumatoid arthritis, or vitiligo.^[2]

Classic Diagnostic Methods for Identifying Graves’ Disease

When you visit your doctor with symptoms that suggest Graves’ disease, the diagnostic process typically begins with a thorough physical examination and discussion of your medical history. Your doctor will ask about recent weight changes, whether you’ve noticed increased nervousness or shakiness, if you’ve been experiencing palpitations or feeling unusually warm, and whether you’ve had changes in bowel habits or menstrual cycles.^[5] Understanding your family history is also important since Graves’ disease has a strong genetic component, with genes contributing to about 79% of the risk of developing the condition.^[3]

During the physical examination, your doctor will carefully feel your neck to check if your thyroid gland is enlarged. An enlarged thyroid is common in Graves’ disease and may feel smooth and diffuse. The doctor may also use a stethoscope to listen for abnormal blood flow near the thyroid gland, which can produce sounds called bruits.^[6] Your doctor will check for other physical signs throughout your body that indicate hyperthyroidism, such as a fast or irregular heart rate, hand tremors when you extend your arms, overly active reflexes when tendons are tapped, warm and moist skin, and eye changes including bulging or a characteristic staring appearance.^[5]

Blood Tests

Blood tests are the cornerstone of diagnosing Graves’ disease and remain the best screening approach for thyroid disorders. The most important initial blood test measures thyroid-stimulating hormone, or TSH, which is produced by the pituitary gland in the brain. The pituitary normally uses TSH to tell the thyroid how much hormone to produce, creating a tightly controlled feedback loop. In Graves’ disease, this normal control system is disrupted.^[6] People with Graves’ disease typically have lower than normal levels of TSH because the thyroid is already producing too much hormone on its own, so the pituitary tries to shut down further production by reducing TSH.^[7]

Along with TSH, your doctor will measure the levels of actual thyroid hormones in your blood. The main thyroid hormones are called thyroxine, or T4, and triiodothyronine, or T3. In Graves’ disease, these hormone levels are higher than normal because the thyroid is overactive.^[7] The combination of low TSH with high thyroid hormone levels strongly suggests hyperthyroidism, but additional testing is needed to confirm that Graves’ disease specifically is the cause.

A crucial blood test for diagnosing Graves’ disease measures the antibodies that cause the condition. These antibodies are called thyroid-stimulating immunoglobulins, or TSI, and are also known as thyroid-stimulating antibodies, or TSAb. In Graves’ disease, the immune system produces these abnormal antibodies that mistakenly attach to receptors on thyroid cells and stimulate them to produce excessive amounts of thyroid hormone.^[4] Finding these antibodies in your blood confirms the diagnosis of Graves’ disease. If these antibodies are not present, your doctor will look for other possible causes of hyperthyroidism.^[7]

Radioactive Iodine Uptake Test

The thyroid gland needs iodine from food to manufacture thyroid hormones. The radioactive iodine uptake test takes advantage of this fact to show how the thyroid is functioning. For this test, you take a small amount of radioactive iodine by mouth, usually in capsule or liquid form. The radioactive iodine is safe and only mildly radioactive. After you swallow it, you wait for a period of time while the iodine circulates through your bloodstream and gets taken up by your thyroid gland.^[7]

A few hours later, or sometimes the next day, you return to have your thyroid measured with a special scanning camera. This camera can detect the radioactivity and show how much radioactive iodine your thyroid has absorbed. The test measures how fast your thyroid takes up iodine, which reflects how active the gland is. In Graves’ disease, the overactive thyroid absorbs radioactive iodine more rapidly and in larger amounts than a normal thyroid would.^[7] This pattern helps distinguish Graves’ disease from other conditions that cause hyperthyroidism.

Sometimes the radioactive iodine test is combined with a radioactive iodine scan, which creates an actual picture showing the pattern of iodine uptake across the thyroid gland. In Graves’ disease, the uptake pattern is typically diffuse, meaning the entire thyroid gland is uniformly overactive rather than having isolated areas of increased activity.^[7] This uniform pattern helps confirm the diagnosis and rules out conditions like toxic nodular goiter, where only certain areas of the thyroid are overactive.

Imaging Studies for Eye Involvement

About one in three people with Graves’ disease develop eye problems, a complication known as Graves’ ophthalmopathy or thyroid eye disease.^[3] This happens when the immune system attacks tissues around the eyes, causing inflammation and swelling. The result can be bulging eyes, double vision, eye pain, light sensitivity, and in severe cases, vision loss. If your doctor suspects that Graves’ disease is affecting your eyes, they may order imaging studies to evaluate the extent of the problem.

Computed tomography, or CT scans, and magnetic resonance imaging, or MRI scans, can show detailed pictures of the tissues and muscles around your eyes. These imaging tests help doctors see if there is swelling or inflammation and determine whether the optic nerve, which is crucial for vision, is being compressed. This information guides treatment decisions and helps prevent permanent damage to your eyesight.^[5]

Heart Testing

Because Graves’ disease affects the heart and can cause a rapid or irregular heartbeat, your doctor may order heart tests to check how well your heart is functioning. An electrocardiogram, or EKG, records the electrical activity of your heart and can detect abnormal heart rhythms such as atrial fibrillation. This simple, painless test involves placing electrodes on your chest while a machine records your heart’s electrical signals.^[5]

If your doctor is concerned about more complex heart problems, additional cardiac tests may be necessary. These might include an echocardiogram, which uses sound waves to create moving pictures of your heart, or other specialized studies. Testing the heart is particularly important in older patients and those with pre-existing heart conditions, as hyperthyroidism from Graves’ disease can worsen heart problems and lead to serious complications.^[5]

Diagnostics for Clinical Trial Qualification

When researchers conduct clinical trials to study new treatments for Graves’ disease, they use standardized diagnostic criteria to decide which patients can participate. These criteria ensure that everyone enrolled in the trial actually has the condition being studied and that results can be compared meaningfully across different participants and studies. Understanding these qualification criteria can help patients know what to expect if they consider joining a clinical trial.

The standard approach for qualifying patients for Graves’ disease clinical trials begins with confirming the diagnosis through blood tests. Researchers typically require evidence of hyperthyroidism, shown by suppressed or undetectable TSH levels along with elevated thyroid hormone levels. Most trials also require proof that the hyperthyroidism is specifically caused by Graves’ disease, which means demonstrating the presence of thyroid-stimulating immunoglobulins or antibodies in the blood.^[6] These antibody tests confirm that the immune system is attacking the thyroid in the characteristic pattern of Graves’ disease rather than another cause of hyperthyroidism.

Clinical trials may use radioactive iodine uptake testing as part of their screening process to verify that the thyroid is diffusely overactive, which is typical of Graves’ disease. This test provides objective measurements that researchers can use to track how well a treatment is working over time. Some trials measure the exact uptake percentage and require it to be above a certain threshold before allowing a patient to enroll.^[7] The uniform pattern of uptake across the entire gland, rather than in isolated spots, confirms that the patient has Graves’ disease rather than other thyroid conditions.

For trials investigating treatments specifically for thyroid eye disease or Graves’ ophthalmopathy, additional diagnostic requirements focus on the eyes. Researchers may require documented evidence of eye involvement using standardized clinical assessments that measure the degree of eye bulging, extent of double vision, amount of swelling around the eyes, and whether vision is affected. Imaging studies such as CT or MRI scans of the orbits, which are the bony sockets that hold the eyes, may be required to objectively measure the extent of inflammation and tissue changes.^[5] These baseline measurements allow researchers to determine whether a treatment successfully reduces eye symptoms.

Clinical trials typically have strict inclusion and exclusion criteria based on diagnostic findings. For example, trials may only accept patients who have been newly diagnosed with Graves’ disease or those whose disease has relapsed after previous treatment. Some trials exclude patients whose thyroid hormone levels are extremely high or who have certain heart complications, as these individuals might need immediate standard treatment rather than experimental therapy. Other trials may specifically seek patients with severe disease or those who haven’t responded to conventional treatments.^[9]

Before enrolling in a clinical trial, patients undergo comprehensive baseline testing that goes beyond what’s needed for routine clinical diagnosis. This typically includes detailed thyroid function tests measuring multiple thyroid hormones and antibody levels, complete blood counts to check overall health, liver and kidney function tests to ensure the patient can safely process study medications, and heart tests including electrocardiograms. Some trials require imaging of the thyroid gland using ultrasound to measure its size and structure, providing baseline data that researchers can compare to later measurements.^[6]

For trials studying long-term management of Graves’ disease, researchers may track thyroid receptor antibody levels over time as a measure of disease activity. Higher antibody levels are associated with a greater risk of the disease relapsing after treatment stops. By monitoring these antibodies, researchers can better understand which patients are most likely to achieve lasting remission and which might need different treatment approaches.^[9] This information helps guide both the conduct of the clinical trial and future treatment decisions for patients with Graves’ disease.

Clinical trials may also assess quality of life using standardized questionnaires as part of their diagnostic workup. While not traditional medical diagnostics, these patient-reported measures help researchers understand how Graves’ disease affects daily functioning, mental health, and overall well-being. Improvements in these quality-of-life measures, alongside objective medical test results, provide a complete picture of whether a new treatment is truly beneficial.^[9]